The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3).
 
Mitesh J. Borad
Stock and Other Ownership Interests - AVEO; AVEO; AVEO; AVEO; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline
Consulting or Advisory Role - Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); ArQule (Inst); ArQule (Inst); ArQule (Inst); ArQule (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Fujifilm (Inst); Fujifilm (Inst); Fujifilm (Inst); Fujifilm (Inst); G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Inspyr Therapeutics; Inspyr Therapeutics; Inspyr Therapeutics; Inspyr Therapeutics; Insys Therapeutics (Inst); Insys Therapeutics (Inst); Insys Therapeutics (Inst); Insys Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pieris Pharmaceuticals (Inst); Pieris Pharmaceuticals (Inst); Pieris Pharmaceuticals (Inst); Pieris Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); TD2; TD2; TD2; TD2
Research Funding - Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); ARIAD (Inst); ARIAD (Inst); ARIAD (Inst); ARIAD (Inst); BiolineRx (Inst); BiolineRx (Inst); BiolineRx (Inst); BiolineRx (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Dicerna (Inst); Dicerna (Inst); Dicerna (Inst); Dicerna (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); ImClone Systems (Inst); ImClone Systems (Inst); ImClone Systems (Inst); ImClone Systems (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Isis Pharmaceuticals (Inst); Isis Pharmaceuticals (Inst); Isis Pharmaceuticals (Inst); Isis Pharmaceuticals (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); miRNA Therapeutics (Inst); miRNA Therapeutics (Inst); miRNA Therapeutics (Inst); miRNA Therapeutics (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Senhwa Biosciences (Inst); Senhwa Biosciences (Inst); Senhwa Biosciences (Inst); Senhwa Biosciences (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Sun Biopharma (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Threshold Pharmaceuticals (Inst); Threshold Pharmaceuticals (Inst); Threshold Pharmaceuticals (Inst); Threshold Pharmaceuticals (Inst); Toray Industries (Inst); Toray Industries (Inst); Toray Industries (Inst); Toray Industries (Inst)
Travel, Accommodations, Expenses - ArQule; ArQule; ArQule; ArQule; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene
 
John A. Bridgewater
Honoraria - Merck Serono; Merck Serono; Merck Serono; Merck Serono; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Basilea; Basilea; Basilea; Bayer; Bayer; Bayer; Bayer; Incyte; Incyte; Incyte; Incyte; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene
Research Funding - Amgen; Amgen; Amgen; Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; SERVIER; SERVIER; SERVIER; SERVIER
 
Chigusa Morizane
Honoraria - Eisai; Eisai; Eisai; Eisai; Fujifilm; Fujifilm; Fujifilm; Fujifilm; Lilly; Lilly; Lilly; Lilly; Nobelpharma; Nobelpharma; Nobelpharma; Nobelpharma; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Research Funding - Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); J-Pharma (Inst); J-Pharma (Inst); J-Pharma (Inst); J-Pharma (Inst); Nobelpharma (Inst); Nobelpharma (Inst); Nobelpharma (Inst); Nobelpharma (Inst); ONO PHARMACEUTICAL (Inst); ONO PHARMACEUTICAL (Inst); ONO PHARMACEUTICAL (Inst); ONO PHARMACEUTICAL (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst)
 
Rachna T. Shroff
Consulting or Advisory Role - Agios; Agios; Agios; Agios; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics; Seagen; Seagen; Seagen; Seagen
Research Funding - Agios; Agios; Agios; Agios; Exelixis; Exelixis; Exelixis; Exelixis; Halozyme; Halozyme; Halozyme; Halozyme; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Zymeworks; Zymeworks; Zymeworks; Zymeworks
Research Funding - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly
 
Markus H. Moehler
Honoraria - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Servier; Servier; Servier; Servier; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Nordic Group; Nordic Group; Nordic Group; Nordic Group; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Jennerex (Inst); Jennerex (Inst); Jennerex (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; ASCO; ASCO; ASCO; ASCO; Bayer; Bayer; Bayer; Bayer; ESMO; ESMO; ESMO; ESMO; German Cancer Society; German Cancer Society; German Cancer Society; German Cancer Society; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
 
Junji Furuse
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; EA Pharma; EA Pharma; EA Pharma; EA Pharma; Eisai; Eisai; Eisai; Eisai; Fujifilm; Fujifilm; Fujifilm; Fujifilm; J-Pharma; J-Pharma; J-Pharma; J-Pharma; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Lilly Japan; Lilly Japan; Lilly Japan; Lilly Japan; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Mochida Pharmaceutical Co. Ltd.; Mochida Pharmaceutical Co. Ltd.; Mochida Pharmaceutical Co. Ltd.; MSD; MSD; MSD; MSD; Nihon Servier; Nihon Servier; Nihon Servier; Nihon Servier; Nippon Kayaku; Nippon Kayaku; Nippon Kayaku; Nippon Kayaku; Novartis; Novartis; Novartis; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi; Sawai Pharmaceutical Co; Sawai Pharmaceutical Co; Sawai Pharmaceutical Co; Sawai Pharmaceutical Co; Shionogi; Shionogi; Shionogi; Shionogi; Shire; Shire; Shire; Shire; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda; Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Eisai; Eisai; Eisai; Eisai; Fujifilm; Fujifilm; Fujifilm; Fujifilm; J-Pharma; J-Pharma; J-Pharma; J-Pharma; Lilly Japan; Lilly Japan; Lilly Japan; Lilly Japan; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Otsuka; Otsuka; Otsuka; Otsuka; Shire; Shire; Shire; Shire; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takara Bio; Takara Bio; Takara Bio; Takara Bio; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); J-Pharma (Inst); J-Pharma (Inst); J-Pharma (Inst); J-Pharma (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); NanoCarrier (Inst); NanoCarrier (Inst); NanoCarrier (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Sumitomo Dainippon (Inst); Sumitomo Dainippon (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst); Yakult Honsha (Inst)
 
Karim A. Benhadji
Employment - Lilly; Lilly; Lilly; Lilly; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Stock and Other Ownership Interests - Lilly; Lilly; Lilly; Lilly
 
Helen He
Employment - Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Juan W. Valle
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Agios; Agios; Agios; Agios; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Keocyt; Keocyt; Keocyt; Keocyt; Merck; Merck; Merck; Merck; Mundipharma; Mundipharma; Mundipharma; Mundipharma; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana; PCI Biotech; PCI Biotech; PCI Biotech; PCI Biotech; Pfizer; Pfizer; Pfizer; Pfizer; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics; SERVIER; SERVIER; SERVIER; SERVIER; Wren Laboratories; Wren Laboratories; Wren Laboratories; Wren Laboratories
Speakers' Bureau - Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Nucana; Nucana; Nucana; Nucana; Pfizer; Pfizer; Pfizer; Pfizer